Ā | Hazard ratio | 95% CI | P-value |
---|---|---|---|
Age (per 1Ā year increase) | 1.02 | 0 .99 -1.034 | 0.171 |
Gender | |||
āFemale | Reference | Ā | Ā |
āMale | 1.19 | 0.78ā1.83 | 0.419 |
Histology | |||
āAdenocarcinoma | Reference | Ā | Ā |
āSquamous | 1.37 | 0.83ā2.26 | 0.218 |
āother types | 1.33 | 0.78 2.27 | 0.303 |
Treatment | |||
āNon-surgical (nĀ =Ā 76) | Reference | Ā | Ā |
āSurgical (nĀ =Ā 24) | 0.4 | 0.22 -0.71 | 0.002 |
āNo treatment (nĀ =Ā 10) | 0.99 | 0.47 -2.1 | 0.986 |
ln(MTVwb) | 1.23 | 1.01ā1.49 | 0.037 |
ln(TLGwb) | 1.13 | 0.95ā1.34 | 0.175 |
In(SUVmaxwb) | 0.91 | 0.57ā1.43 | 0.67 |